Sartorius Stedim Biotech SA is a France-based international provider of laboratory and process technologies and equipment. The Company covers the segments of biotechnology and mechatronics. Sartorius provides services which help customers to implement complex and quality-critical processes in biopharmaceutical production and laboratory environments in a time- and cost-efficient way.
Market: Euronext Paris
Fair value: 68€
Discount: 14%
Average yearly return: 45%
Yield: 0.51%
Outperformer
Buy
On May 4, 2016
The Company announced:
The split by 6 of the Sartorius Stedim Biotech shares (DIM FP | STDM.PA) and the respective adjustment of the par value per share will become effective May 10, 2016. The share split will be conducted automatically, without any additional costs or formalities for the shareholders and will have no impact on their rights. The operation was approved by the Annual General Shareholders’ Meeting (AGM) on April 5, 2016, following a significant increase in the share price over the past two years and aims at increasing the tradability of Sartorius Stedim Biotech shares.
After the split, the share capital of Sartorius Stedim Biotech S.A. will be divided into 92,180,190 shares.
No comments:
Post a Comment